Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Visit http://indiaer.blogspot.com/ for complete details �� ��
Pfizer Dec-Mar'11 Result Update; Muted growth; Maintain Accumulate; Target: Rs1,417
n Muted performance by Pfizer with a) Revenue up by 12.3%* to Rs3.1bn, b) EBIDTA up by 2%* to Rs703mn and c) APAT increased by 12%* to Rs631mn
n Pharma revenue growth lower than industry growth of ~16% due to lower growth in Becosules
n Company declared dividend of Rs16.50 per share for 16 month period with dividend yield of 1.3%
n Value company at 18x FY13 EPS of Rs78.7 to arrive at a target price of Rs1417 and maintain Accumulate rating
No comments:
Post a Comment